Vandetanib Completed Phase 1 Trials for Pharmacokinetics / (t1/2,λz) / Plasma [AUC(0-t)] / Tmax / Cmax / Plasma AUC / Plasma [AUC(0-672)] Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT01539655Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib